CLINICAL_TRIALS trial_result · 2015-07-14

Clinical Trial Update: Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome [Phase 2]

A Phase 2 dose-escalation trial of rotigotine in pediatric patients with Restless Legs Syndrome has completed, with results posted on 2015-07-14.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: UCB BIOSCIENCES, Inc. | Conditions: Restless Legs Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2015-07-14